IMMUTEP Ltd Files Routine 6-K Report
Ticker: PRRUF · Form: 6-K · Filed: Jun 25, 2024 · CIK: 1506184
| Field | Detail |
|---|---|
| Company | Immutep Ltd (PRRUF) |
| Form Type | 6-K |
| Filed Date | Jun 25, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-K, compliance
Related Tickers: IMMU
TL;DR
IMMUTEP Ltd (IMMU) filed a standard 6-K, no major news, just compliance.
AI Summary
On June 24, 2024, IMMUTEP Ltd filed a Form 6-K, reporting its status as a foreign private issuer. The company, formerly known as Prima BioMed Ltd, is based in Sydney, Australia, and operates in the Pharmaceutical Preparations industry. This filing does not contain specific financial updates or material events beyond its routine reporting requirements.
Why It Matters
This filing confirms IMMUTEP Ltd's ongoing compliance with SEC reporting requirements for foreign private issuers, providing transparency to investors about its corporate status.
Risk Assessment
Risk Level: low — This is a routine administrative filing and does not contain new material information that would typically impact risk.
Key Players & Entities
- IMMUTEP Ltd (company) — Filer of the 6-K report
- Prima BioMed Ltd (company) — Former name of IMMUTEP Ltd
- 20240624 (date) — Date of report
- 001-35428 (other) — SEC file number
FAQ
What is the purpose of this Form 6-K filing by IMMUTEP Ltd?
The Form 6-K is a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to provide information that the company makes or is required to make public in its home country or to shareholders.
When was this Form 6-K filed?
The filing date is June 25, 2024, and the report is dated June 24, 2024.
What is IMMUTEP Ltd's former company name?
IMMUTEP Ltd was formerly known as Prima BioMed Ltd.
Where is IMMUTEP Ltd's principal executive office located?
The principal executive office is located at Level 32, Australia Square, 264 George Street, Sydney NSW 2000, Australia.
Does IMMUTEP Ltd file its annual reports under Form 20-F or Form 40-F?
IMMUTEP Ltd indicates that it files its annual reports under cover of Form 20-F.
Filing Stats: 252 words · 1 min read · ~1 pages · Grade level 15.4 · Accepted 2024-06-24 20:32:28
Filing Documents
- d717414d6k.htm (6-K) — 9KB
- d717414dex991.htm (EX-99.1) — 13KB
- g717414g63s00.jpg (GRAPHIC) — 12KB
- 0001193125-24-167211.txt ( ) — 39KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Dated: June 24, 2024 IMMUTEP LIMITED By: /s/ Marc Voigt Name: Marc Voigt Title: Chief Executive Officer